Cargando…
A Clinically Relevant Dosage of Mitoxantrone Disrupts the Glutathione and Lipid Metabolic Pathways of the CD-1 Mice Brain: A Metabolomics Study
Long-term cognitive dysfunction, or “chemobrain”, has been observed in cancer patients treated with chemotherapy. Mitoxantrone (MTX) is a topoisomerase II inhibitor that binds and intercalates with DNA, being used in the treatment of several cancers and multiple sclerosis. Although MTX can induce ch...
Autores principales: | Dias-Carvalho, Ana, Margarida-Araújo, Ana, Reis-Mendes, Ana, Sequeira, Catarina Oliveira, Pereira, Sofia Azeredo, Guedes de Pinho, Paula, Carvalho, Félix, Sá, Susana Isabel, Fernandes, Eduarda, Costa, Vera Marisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488007/ https://www.ncbi.nlm.nih.gov/pubmed/37685929 http://dx.doi.org/10.3390/ijms241713126 |
Ejemplares similares
-
Cardiac Molecular Remodeling by Anticancer Drugs: Doxorubicin Affects More Metabolism While Mitoxantrone Impacts More Autophagy in Adult CD-1 Male Mice
por: Brandão, Sofia Reis, et al.
Publicado: (2023) -
Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice
por: Reis-Mendes, Ana, et al.
Publicado: (2021) -
Hepatic Metabolic Derangements Triggered by Hyperthermia: An In Vitro Metabolomic Study
por: Araújo, Ana Margarida, et al.
Publicado: (2019) -
Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions
por: Araújo, Ana Margarida, et al.
Publicado: (2021) -
Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies
por: Lima, Ana Rita, et al.
Publicado: (2016)